This site is intended for healthcare professionals
Light microscopy of the internal lining of the urinary bladder; haematoxylin and eosin stain
Learning Zone

Managing High-Risk NMIBC

Last updated: 25th Jun 2025
Published: 20th Jan 2025

The treatment landscape for high-risk non-muscle-invasive bladder cancer (NMIBC) is rapidly evolving. This resource aims to equip you with the information you need to select the right treatment options for your patients, with focused overviews of diagnostic and treatment pathways, plus the latest from ASCO GU, EAU, AUA, and ASCO.

And keep an eye out for our NMIBC podcast series, with a focus on tackling clinical challenges in providing optimal care, launching soon.

ASCO 2025: Expert interviews

Hear from Thomas Powles and Gary Steinberg about recent trial data presented at ASCO 2025 and the potential impact for NMIBC management.

Watch now

 

Complete the form below to receive our regular round-up of the latest clinical news and medical education resources on Medthority, straight to your inbox.

* = required information 

 

By providing your email address, you are opting in to receive our monthly newsletter.

We will never share your data, and you can withdraw consent at any time. Read our privacy policy here.

Welcome:
Updates in your area
of interest
Articles your peers
are looking at
Bookmarks
saved
Days to your
next event